A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group
Meredith K. Chuk, Brigitte C. Widemann, Charles G. Minard, Xiaowei Liu, Ae Rang Kim, Melanie Brooke Bernhardt, Rachel A. Kudgus, Joel M. Reid, Stephan D. Voss, Susan Blaney, Elizabeth Fox, Brenda J. Weigel
Dive into the research topics of 'A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group'. Together they form a unique fingerprint.